ExoLabz logo
support@exolabz.co
Out-of-Specification Results and What a Retest Can Prove

Out-of-Specification Results and What a Retest Can Prove

Hold a certificate up and ask it how many times the assay was run. It will not tell you. Nor will it say whether any determination was set aside, or what an investigation decided, or whether an investigation took place. All it carries is the figure that was reported at the end. A spotless certificate is equally consistent with a clean first measurement and with weeks of documented inquiry that eventually justified invalidating an earlier one.

No scandal in that; reporting a lot against its limits is the whole job of the document. The consequence is simply that most of the confidence a certificate carries rests on whether the laboratory behind it operates a defined procedure for handling failures at all. Accreditation is the usual outside check on that question, subject to the scope caveats in what ISO/IEC 17025 accreditation covers, and the incentives differ by arrangement in the way described in third-party versus in-house testing.

Data does not become un-data

Here is the rule everything else follows from. The moment an instrument produces a number, that number is data. A later measurement, however much more convenient, cannot retract it. A laboratory that keeps testing and keeps discarding until something passes has stopped measuring and started choosing.

This is not pedantry about recordkeeping. Take a lot that genuinely sits on its limit: run the assay often enough and chance alone will eventually hand you a value on the right side of the line. Publish that value alone and a coin toss has been laundered into a certificate.

The order an investigation has to follow

When a result fails, the formal answer is an investigation, and its object is to work out whether what failed was the material or the measurement. The order is not arbitrary. Everything begins in the laboratory: was there a traceable mistake — a standard weighed wrong, a mobile phase made up incorrectly, a suitability sequence that did not pass, a number copied across badly? Those checks are the ordinary ones set out in system suitability.

Whatever turns up there has to be found, not supposed. Saying the instrument probably drifted identifies nothing; a calibration record that shows the drift identifies something. Only once the laboratory phase closes without a cause does attention move to the material. At that point the result is a property of the sample, and the live question becomes whether the sample stood in fairly for the lot — which is the subject of sampling plans and batch representation.

One legitimate use of a retest, three impostors

Retesting has a narrow proper role, and three misuses that are easy to mistake for it. It is not an appeal: a second number does not overrule the first. Where a laboratory error was identified and fixed, the repeat stands in for a result that has been invalidated; where nothing was found, both numbers are data and the material is out of specification on the weight of them.

It is not a search either. Running the assay until a passing figure surfaces — testing into compliance, as it is sometimes called — turns the logic of measurement inside out. And it is no substitute for sampling more widely: reinjecting one vial interrogates the injection, re-preparing from the same aliquot interrogates the preparation, and only fresh material drawn from the lot interrogates the lot.

The number of retests allowed, where the material for them comes from, and whose signature authorizes them all belong in the written procedure before anybody sees a result. A retest allowance settled on after the first failure is not a rule. It is a negotiation.

The 97.2 and 99.0 problem

Suppose two determinations come in at 97.2% and 99.0%, and the pair is averaged to 98.1%. The lot is now reported as compliant, and a spread of nearly two percent — in the method, the sample or the material, and it matters which — has disappeared from view. That spread is far larger than the uncertainty discussed in measurement uncertainty, and it was the most interesting thing the testing found.

Averaging is fine where it was designed into the method from the outset. A method that calls for the mean of three preparations reports that mean, and no single preparation is a result on its own. What is not fine is a method calling for one determination, a failure, a second run, and a quiet average of the two.

Three ways a number can be wrong; one breaches a limit

CategoryWhat happenedExample
Out of specificationFalls outside an acceptance criterionPurity below the stated limit
Out of trendPasses, but departs from lot history98.2% where history clusters at 99.4%
Out of expectationAnomalous with no limit attachedUnexpected peak, shifted retention time, unpredicted mass

The middle row still signals that something changed, in the manner covered in lot-to-lot variation and trending. Neither the middle nor the bottom row will ever reach a certificate, since a certificate weighs one lot against its own limits. Both are visible only to whoever keeps the history, and that is one of the structural blind spots in reading any single report.

Three honest endings

When a lot has genuinely failed, the menu is short, and reporting a nicer figure is not on it:

  • Reject the lot.
  • Reprocess it, then test it as a new lot under a new identifier, per batch and lot numbering.
  • Release it against a different, lower specification, with that specification printed on the report.

The third is perfectly proper and appears far less often than it ought to. Material called 94% against a 94% limit gives a buyer something to work with. The same material called 98% because the third determination obliged does not.

Leave a Comment

Your email address will not be published. Required fields are marked *

*
*

Legal Disclaimer

The products offered by ExoLabz are intended solely for research purposes. These products are not for human consumption, are not intended for medical use, and have not been approved by the FDA for any therapeutic or diagnostic purpose. ExoLabz makes no claims regarding the safety, efficacy, or intended use of these products outside of a controlled research environment. By purchasing our products, you agree to use them strictly for scientific research and in compliance with all local laws and regulations.

GLP-1 15mg research peptide vial - ExoLabz USA

Copyright © ExoLabz 2026 | All rights reserved.

Research Peptides USA | Where We Ship | Certificates of Analysis | Purity Guarantee | FAQ

Shipping Policy | Payment Methods | Bulk & Repeat Orders | Customer Reviews | Peptide Glossary | Reconstitution Calculator

Choosing a Supplier | Regulatory Status | GHK-Cu | Sermorelin | TB-500 | Research Library

Buy Research Peptides in Alabama | Buy Research Peptides in Alaska | Buy Research Peptides in Arizona | Buy Research Peptides in Arkansas | Buy Research Peptides in California | Buy Research Peptides in Colorado | Buy Research Peptides in Connecticut | Buy Research Peptides in Delaware | Buy Research Peptides in District of Columbia | Buy Research Peptides in Florida | Buy Research Peptides in Georgia | Buy Research Peptides in Hawaii | Buy Research Peptides in Idaho | Buy Research Peptides in Illinois | Buy Research Peptides in Indiana | Buy Research Peptides in Iowa | Buy Research Peptides in Kansas | Buy Research Peptides in Kentucky | Buy Research Peptides in Louisiana | Buy Research Peptides in Maine | Buy Research Peptides in Maryland | Buy Research Peptides in Massachusetts | Buy Research Peptides in Michigan | Buy Research Peptides in Minnesota | Buy Research Peptides in Mississippi | Buy Research Peptides in Missouri | Buy Research Peptides in Montana | Buy Research Peptides in Nebraska | Buy Research Peptides in Nevada | Buy Research Peptides in New Hampshire | Buy Research Peptides in New Jersey | Buy Research Peptides in New Mexico | Buy Research Peptides in New York | Buy Research Peptides in North Carolina | Buy Research Peptides in North Dakota | Buy Research Peptides in Ohio | Buy Research Peptides in Oklahoma | Buy Research Peptides in Oregon | Buy Research Peptides in Pennsylvania | Buy Research Peptides in Rhode Island | Buy Research Peptides in South Carolina | Buy Research Peptides in South Dakota | Buy Research Peptides in Tennessee | Buy Research Peptides in Texas | Buy Research Peptides in Utah | Buy Research Peptides in Vermont | Buy Research Peptides in Virginia | Buy Research Peptides in Washington | Buy Research Peptides in West Virginia | Buy Research Peptides in Wisconsin | Buy Research Peptides in Wyoming

Shipping Policy | Bulk Peptide Orders | Payment Methods | Research Peptides USA | Where We Ship | Research Peptide Glossary

0
    0
    Your Cart
    Your cart is empty